Mepivacaine
Amides
- Drug class
- Amides
- Availability
- Prescription only
- Routes
- Submucosal
- Markets covered
- 2
- Products on record
- 2
Overview
Plain-language summary, compiled from the cited regulatory records
Mepivacaine is a local anesthetic belonging to the amide class of drugs [1]. It is approved for use in dental procedures to produce local anesthesia in both adults and pediatric patients [1]. This can be achieved through infiltration or nerve block techniques [1].
Mepivacaine is available under various brand names [1]. While specific brand examples were not provided in the data, it is recognized as a commonly used agent in dental anesthesia [1]. The drug functions by blocking nerve signals in the area where it is applied, thereby preventing the sensation of pain during dental work [1].
Information regarding adverse event reports for Mepivacaine was not available for the specified period [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 1 | February 21, 2024 |
| GB United Kingdom | MHRA | 1 | April 10, 2026 |
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
Mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients.
How to take
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Drug interactions
Known interactions involving Mepivacaine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 042010fb-7161-43… · revised February 21, 2024 [PDF]
- [2]MHRA (UK) · PL083130023 · revised April 10, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.